Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial

  1. Ravassa, S.
  2. Trippel, T.
  3. Bach, D.
  4. Bachran, D.
  5. González, A.
  6. López, B.
  7. Wachter, R.
  8. Hasenfuss, G.
  9. Delles, C.
  10. Dominiczak, A.F.
  11. Pieske, B.
  12. Díez, J.
  13. Edelmann, F.
Aldizkaria:
European Journal of Heart Failure

ISSN: 1879-0844,  1388-9842

Argitalpen urtea: 2018

Alea: 20

Zenbakia: 9

Orrialdeak: 1290-1299

Mota: Artikulua

DOI: 10.1002/EJHF.1194 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus